It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2017.
2017 | Chennai, Tamil Nadu, India | ActiveGrandix Global Pharma Private Limited, a active private limited company, was established on 29 May 2017 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909TN2017PTC116820. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.91 M.
Formerly known as Avaance Lifesciences Private Limited. It upholds a compliant status. Its leadership includes Karnnanidhi Venneela Ramanar (Director), Latha Subramanian (Director). Past directors included Venkataraghavan Sourirajan, Latha Subramanian. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 253, 2Nd Street, Velan Nagar, Valasaravakkam,, Chennai, Tamil Nadu, 600087.
U51909TN2017PTC116820
116820
29 May 2017
₹3.00 M
₹1.91 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Grandix Global Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karnnanidhi Venneela Ramanar | Director | 29 May 2017 | Current |
| Latha Subramanian | Director | 01 Apr 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Grandix Global Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 41.14% decrease. The company also saw a substantial improvement in profitability, with a 121.57% increase in profit. The company's net worth moved up by a moderate rise of 2.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Grandix Global Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Grandix Global Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Grandix Global Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grandix Global Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Grandix Global Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Latha Subramanian was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 8 months . was documented.
The activity Grandix Global Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
The activity Karnnanidhi Venneela Ramanar was appointed as a Director was appointed as a Director on 29 May 2017 & has been associated with this company since 8 years 6 months . was completed.
Progress on Grandix Global Pharma Private Limited was registered on 29 May 2017 with Roc Chennai & aged 8 years 6 months as per MCA records. was documented.
The CIN of Grandix Global Pharma Private Limited is U51909TN2017PTC116820.
Grandix Global Pharma Private Limited is headquartered at No. 253, 2Nd Street, Velan Nagar, Valasaravakkam,, Chennai, Tamil Nadu, 600087.
Grandix Global Pharma Private Limited was incorporated on 29 May 2017.
The current directors of Grandix Global Pharma Private Limited are
The primary industry of Grandix Global Pharma Private Limited is Pharma.
Grandix Global Pharma Private Limited is unlisted.
The authorized capital of Grandix Global Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹1.91 M.
The compliance status of Grandix Global Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX